α-Mannosidase II Inhibitor Development Service at CD BioGlyco

CD BioGlyco aims to provide strong support to clients in the development of Glycosylation Inhibitors. α-Mannosidase II is predominantly found in the Golgi, lysosomes, endoplasmic reticulum, and cytoplasm of eukaryotes. As a key glycosidase, it is involved in N-Glycan Modification Processes. Its catalytic process is Zn²⁺-dependent. Swainsonine inhibits its activity. α-Mannosidase II function abnormally causes structural changes in cell surface N-glycans, which affects cell growth and differentiation. α-Mannosidase II inhibitors are very necessary to be developed. We provide a one-stop service for the development of α-mannosidase II inhibitors. Our α-mannosidase II inhibitor development directions include but are not limited to the following.

• Inhibitor development services based on α-mannosidase II substrates

Higher concentrations of substrate analogs may act as metabolic inhibitors. We will screen corresponding substrate analogs to inhibit the activity of α-mannosidase II by binding to it.

• Natural inhibitor screening service

Swainsonine, mannostatin A, etc. are compounds that inhibit α-mannosidase II isolated from plants such as Astragalus stellatus. We screen plants and animals for natural compounds that inhibit α-mannosidase II. We have special screening tools to improve the efficiency of inhibitor development.

• Inhibitor development services in other directions

Swainsonine is an effective α-mannosidase II inhibitor. We are trying to synthesize swainsonine analogs and test their inhibitory effect on α-mannosidase II. We also try to screen and synthesize other oligosaccharides-based scaffolds, such as iminosugars.

Fig.1 Process for the development of α-mannosidase II inhibitors. (CD BioGlyco)

Publication

Applications of α-Mannosidase II Inhibitor Development

• α-Mannosidase II is related to plant growth and development. The development of α-mannosidase II inhibitors plays an important role in the study of plant growth regulation.
• The development of α-mannosidase II inhibitors plays an important role in the study of the function of α-mannosidase II.
• The abnormal function of α-mannosidase II causes abnormal N-glycan metabolism in the organism, which leads to a variety of diseases. The development of α-mannosidase II inhibitors plays an important role in the research of therapeutic approaches for diseases.

Highlights of Us

• We build specialized natural product libraries and other compound libraries for α-Mannosidase II inhibitor development.
• We have the capability of high-throughput screening, which greatly shortens compound screening time.
• Our α-mannosidase II inhibitors are developed in a variety of directions to meet the needs of different customer studies.

CD BioGlyco has extensive knowledge and experience in the development of Glycosidase Inhibitors, etc. We aim to provide efficient and high-quality inhibitor development services for our clients of glycosylation research. Please feel free to contact us to learn more about the detailed protocols and experimental procedures for inhibitor development.